United States (US) Glaucoma Market (2025-2031) | Outlook, Growth, Trends, Forecast, Share, Analysis, Size & Revenue, Value, Segmentation, Competitive Landscape, Industry, Companies

Market Forecast By Type (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma, Others), By Drug Class (Beta Blockers, Prostaglandins, Alpha Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Combination Drugs, Others), By Route of Administration (Oral, Injections, Intravitreal, Others), By End-Users (Hospitals, Speciality Centres, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) And Competitive Landscape
Product Code: ETC9966983 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Glaucoma Market Outlook
  • Market Size of United States (US) Glaucoma Market, 2024
  • Forecast of United States (US) Glaucoma Market, 2031
  • Historical Data and Forecast of United States (US) Glaucoma Revenues & Volume for the Period 2021- 2031
  • United States (US) Glaucoma Market Trend Evolution
  • United States (US) Glaucoma Market Drivers and Challenges
  • United States (US) Glaucoma Price Trends
  • United States (US) Glaucoma Porter's Five Forces
  • United States (US) Glaucoma Industry Life Cycle
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Closed Angle Glaucoma (CAG) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Open Angle Glaucoma (OAG) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Secondary Glaucoma for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Congenital Glaucoma for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Beta Blockers for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Prostaglandins for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Alpha Adrenergic Agonist for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Carbonic Anhydrase Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Combination Drugs for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Injections for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Intravitreal for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Speciality Centres for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Glaucoma Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • United States (US) Glaucoma Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-Users
  • Market Opportunity Assessment By Distribution Channel
  • United States (US) Glaucoma Top Companies Market Share
  • United States (US) Glaucoma Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Glaucoma Company Profiles
  • United States (US) Glaucoma Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Glaucoma Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Glaucoma Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Glaucoma Market - Industry Life Cycle

3.4 United States (US) Glaucoma Market - Porter's Five Forces

3.5 United States (US) Glaucoma Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Glaucoma Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.7 United States (US) Glaucoma Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United States (US) Glaucoma Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.9 United States (US) Glaucoma Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Glaucoma Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Glaucoma Market Trends

6 United States (US) Glaucoma Market, By Types

6.1 United States (US) Glaucoma Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Glaucoma Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Glaucoma Market Revenues & Volume, By Closed Angle Glaucoma (CAG), 2021- 2031F

6.1.4 United States (US) Glaucoma Market Revenues & Volume, By Open Angle Glaucoma (OAG), 2021- 2031F

6.1.5 United States (US) Glaucoma Market Revenues & Volume, By Secondary Glaucoma, 2021- 2031F

6.1.6 United States (US) Glaucoma Market Revenues & Volume, By Congenital Glaucoma, 2021- 2031F

6.1.7 United States (US) Glaucoma Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Glaucoma Market, By Drug Class

6.2.1 Overview and Analysis

6.2.2 United States (US) Glaucoma Market Revenues & Volume, By Beta Blockers, 2021- 2031F

6.2.3 United States (US) Glaucoma Market Revenues & Volume, By Prostaglandins, 2021- 2031F

6.2.4 United States (US) Glaucoma Market Revenues & Volume, By Alpha Adrenergic Agonist, 2021- 2031F

6.2.5 United States (US) Glaucoma Market Revenues & Volume, By Carbonic Anhydrase Inhibitors, 2021- 2031F

6.2.6 United States (US) Glaucoma Market Revenues & Volume, By Combination Drugs, 2021- 2031F

6.2.7 United States (US) Glaucoma Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Glaucoma Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) Glaucoma Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United States (US) Glaucoma Market Revenues & Volume, By Injections, 2021- 2031F

6.3.4 United States (US) Glaucoma Market Revenues & Volume, By Intravitreal, 2021- 2031F

6.3.5 United States (US) Glaucoma Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Glaucoma Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 United States (US) Glaucoma Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Glaucoma Market Revenues & Volume, By Speciality Centres, 2021- 2031F

6.4.4 United States (US) Glaucoma Market Revenues & Volume, By Others, 2021- 2031F

6.5 United States (US) Glaucoma Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 United States (US) Glaucoma Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 United States (US) Glaucoma Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.4 United States (US) Glaucoma Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7 United States (US) Glaucoma Market Import-Export Trade Statistics

7.1 United States (US) Glaucoma Market Export to Major Countries

7.2 United States (US) Glaucoma Market Imports from Major Countries

8 United States (US) Glaucoma Market Key Performance Indicators

9 United States (US) Glaucoma Market - Opportunity Assessment

9.1 United States (US) Glaucoma Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Glaucoma Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.3 United States (US) Glaucoma Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United States (US) Glaucoma Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.5 United States (US) Glaucoma Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Glaucoma Market - Competitive Landscape

10.1 United States (US) Glaucoma Market Revenue Share, By Companies, 2024

10.2 United States (US) Glaucoma Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All